VivoSeq
Other

Pelvic Inflammatory Disease

13

Pipeline Programs↗

2

Active Trials↗

7

Companies Involved↗

Pelvic Inflammatory Disease is an emerging landscape with 13 programs across 7 companies. The most active players are Beijing Konruns Pharmaceutical Co., Ltd., WestVac Biopharma Co., Ltd., Changchun BCHT Biotechnology Co.. 6 therapies are approved with 3 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

41/100

Pipeline Velocity

0/100

Mech. Concentration

20/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

B

Beijing Konruns Pharmaceutical Co., Ltd.

1 program

Phase 2W

WestVac Biopharma Co., Ltd.

1 program

Phase 2C

Changchun BCHT Biotechnology Co.

1 program

Phase 2P

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

2 programs

Phase 3Jiangsu Hansoh Pharmaceutical Co., Ltd. logo

Jiangsu Hansoh Pharmaceutical Co., Ltd.

1 program

ApprovedBayer logo

Bayer

3 programs

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

15

clinical trials

Completed9 · 60%
Unknown status4 · 27%
Recruiting2 · 13%

Clinical Trials

Trial Activity

15 trials

A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
Recruiting·BBeijing Konruns Pharmaceutical Co., Ltd.·Phase 3·NCT05970783·414 enrolled
Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain
Recruiting·—·N/A·NCT06360965·102 enrolled
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
Completed·—·Phase 2·NCT01160640·233 enrolled
A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease
Completed·Bayer logoBayer·Phase 3·NCT00453349·460 enrolled
Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan
Completed·Pfizer logoPfizer·Phase 3·NCT00871494·76 enrolled
The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
Completed·BBeijing Konruns Pharmaceutical Co., Ltd.·Phase 2·NCT05460546·180 enrolled
Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)
Completed·Pfizer logoPfizer·N/A·NCT01671280·403 enrolled
To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment
Completed·GGuilan University of Medical Sciences·Phase 4·NCT01241110·100 enrolled
Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.
Completed·Bayer logoBayer·Phase 3·NCT00683865·749 enrolled
Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases
Completed·UUniversity of Karachi·Phase 2·NCT04723069·198 enrolled
Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials
Completed·IIstanbul Bakirkoy Maternity and Children Diseases Hospital·Phase 4·NCT01799356·1,303 enrolled
A Clinical Study on Qianjin Capsule of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Damp-heat Stasis and Qi Deficiency Syndrome)
Unknown status·CChina Academy of Chinese Medical Sciences·Phase 4·NCT04031664·184 enrolled
Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae
Unknown status·SShanghai University of Traditional Chinese Medicine·Phase 2·NCT02972151·175 enrolled
A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation)
Unknown status·CChina Academy of Chinese Medical Sciences·Phase 4·NCT04035785·240 enrolled
A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease
Unknown status·Jiangsu Hansoh Pharmaceutical Co., Ltd. logoJiangsu Hansoh Pharmaceutical Co., Ltd.·Phase 4·NCT03391440·469 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)